[1] |
Högenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis[J]. N Engl J Med Overseas Ed,2006,355(23):2418-2426.
|
[2] |
Park EA, Kim YT, Cho JH, et al. Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae[J]. Arch Virol,2017,162(4):1129-1139.
|
[3] |
Jackson KJA. Prevalence of Klebsiella oxytoca in Anolis carolensis of Louisiana[J]. Vector Borne Zoonotic Dis,2016,16(12):800-801.
|
[4] |
Ochoa M, Salazar A, Gomez D. Extended-spectrum β-lactamases (ESBL) TEM and SHV in intensive care unit patients with health-care associated infections, silenced genes?[J]. Int J Infect Dis,2018,73:14.
|
[5] |
Kumar Trivedi M. Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment[J]. J Microb Biochem Technol,2015,7(4):202-205..
|
[6] |
Leitner E, Zarfel G, Luxner J, et al. Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward[J]. Antimicrob Agents Chemother,2015,59(1):714-716.
|
[7] |
张文婧, 褚月娇, 王佳贺. 神经外科住院患者医院感染现状的研究进展[J]. 中国医药导报,2019,16(20):38-41.
|
[8] |
冯思语, 胡露露, 毕言伟, 等. 2013-2015年肺炎克雷伯菌和产酸克雷伯菌的临床分布及耐药性分析[J]. 南京医科大学学报,2017(37):328-331.
|
[9] |
Tominaga T. Rapid detection of Klebsiella pneumoniae, Klebsiella oxytoca, Raoultella ornithinolytica and other related bacteria in food by lateral-flow test strip immunoassays[J]. J Microbiol Methods,2018,147:43-49.
|
[10] |
Hastings JW. Chemistries and colors of bioluminescent reactions: a review[J]. Gene,1996,173(1):5-11.
|
[11] |
Hastings JW, Greenberg EP. Quorum sensing: the explanation of a curious phenomenon reveals a common characteristic of bacteria[J]. J Bacteriol,1999,181(9):2667-2668.
|
[12] |
Wang X, Chi H, Zhou B, et al. Bacterial luciferase gene cassette as a real-time bioreporter for infection model and drug evaluation[J]. Curr Pharm Des,2018,24(8):952-958.
|
[13] |
Johnson JK, Robinson GL, Pineles LL, et al. Carbapenem MICs in Escherichia coli and Klebsiella species producing extended-spectrum β-lactamases in critical care patients from 2001 to 2009[J]. Antimicrob Agents Chemother,2017,61(4):AAC.01718-16.
|
[14] |
Li M, Shen X, Yan J, et al. GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2[J]. Mol Microbiol,2011,79(6):1670-1683.
|
[15] |
林静, 何佳茜, 尚翠玲, 等. 5种常见致病菌菌液OD值与其活菌数相关性研究[J]. 天津农学院学报,2017,24(4):42-45.
|
[16] |
朱艳蕾. 细菌生长曲线测定实验方法的研究[J]. 微生物学杂志,2016,36(5):108-112.
|
[17] |
Beaugerie L, Metz M, Barbut F, et al. Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis[J]. Clin Gastroenterol Hepatol,2003,1(5):370-376..
|
[18] |
Dima Y, Babak H, Riederer KM, et al. Klebsiella pneumoniae and K. oxytoca Bacteremia: differences in host, source, and antibiotic susceptibility[J]. Open Forum Infect Dis,2019,6(Supplement_2): S112-S112.
|
[19] |
俞云松. 细菌耐药的流行现状及防控对策[J]. 中华临床感染病杂志,2010,3(3):129-133.
|
[20] |
罗讯, 徐紫慧, 张文劲, 等. 欧盟和北美抗生素耐药性监测调查现状比较[J]. 中国抗生素杂志,2019,44(4):393-400.
|
[21] |
徐艳, 杨怀, 陈黎媛, 等. 中国临床微生物室参与医院感染及抗菌药物使用管理的现状[J]. 中国感染控制杂志,2019,18(2):33-39.
|
[22] |
Bacconi M, Haag AF, Torre A, et al. A stable luciferase reporter plasmid for in vivo imaging in murine models of Staphylococcus aureus infections[J]. Appl Microbiol Biotechnol,2016,100(7):3197- 3206.
|
[23] |
Leschner S, Weiss S. Noninvasive in vivo imaging to follow bacteria engaged in cancer therapy[M]. Bacterial Therapy of Cancer. Humana Press, New York, NY,2016:61-68.
|
[24] |
欧佳美, 胡秋蓉. 微生物检验中细菌耐药性监测的临床应用[J]. 深圳中西医结合杂志,2018,28(16):88-89.
|
[25] |
张昭勇, 高波, 李显东, 等. VAP患者CRE医院感染分子流行病学特征及影响因素[J]. 山东医药,2019,63(25):31-35.
|